Robert J. O'donoghue
Heidelberg, VIC 3084, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Inhibition of the minor spliceosome restricts the growth of a broad spectrum of cancers.
Journal: EMBO reports
Published: February 14, 2025
An unconventional T cell nexus drives HCK-mediated chronic obstructive pulmonary disease in mice.
Journal: EBioMedicine
Published: October 21, 2024
Priming mucosal pathogen-agnostic innate immunity with an intranasal TLR2/6 agonist in an aged population.
Journal: ERJ open research
Published: October 11, 2024
Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma.
Journal: Cell death discovery
Published: June 16, 2021
Plasma cell but not CD20-mediated B-cell depletion protects from bleomycin-induced lung fibrosis.
Journal: The European respiratory journal
Published: May 30, 2021
BCL-XL is an actionable target for treatment of malignant pleural mesothelioma.
Journal: Cell death discovery
Published: August 23, 2020
NLRP1 variant M1184V decreases inflammasome activation in the context of DPP9 inhibition and asthma severity.
Journal: The Journal of allergy and clinical immunology
Published: February 06, 2020
Inhibition of the SRC Kinase HCK Impairs STAT3-Dependent Gastric Tumor Growth in Mice.
Journal: Cancer immunology research
Published: August 15, 2019
IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization.
Journal: Nature communications
Published: January 23, 2018
CD52 inhibits Toll-like receptor activation of NF-κB and triggers apoptosis to suppress inflammation.
Journal: Cell death and differentiation
Published: March 09, 2017
Last Updated: 09/26/2026